The mission of the Center for Neurodegenerative Disease Research (CNDR) is to promote and conduct multidisciplinary clinical and basic research to increase the understanding of the causes and mechanisms leading to brain dysfunction and degeneration in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body dementia (LBD), Frontotemporal degeneration (FTD), Amyotrophic lateral sclerosis (ALS), Primary lateral sclerosis (PLS), Motor neuron disease (MND), and related disorders that occur increasingly with advancing age. Implicit in the mission of the CNDR are two overarching goals: 1.) Find better ways to cure and treat these disorders, 2. Provide training to the next generation of scientists.

“My goal for CNDR is not only to collaborate with researchers at Penn and from institutions across the globe with the mutual goal of finding better ways to diagnose and treat neurodegenerative diseases, but also to inspire and encourage the next generation of scientists on the importance of investigating these disorders that occur more frequently with advancing age.” – Virginia M.-Y. Lee, PhD, Director, CNDR



John Q. Trojanowski, MD, PhD | 1946 - 2022

johnFebruary 8, 2022

We are sad to announce the passing of our colleague and friend, John Q. Trojanowski, who we all regard as a larger than life leader in neurodegenerative disease research.   We will miss his probing intellect, limitless enthusiasm and energy, and ever present personality.  He passed away peacefully with Virginia, his partner in every aspect of his life, by his side.  I know the thoughts of our entire community go out to Virginia and her family.  While today is a difficult day for so many of us, we do look forward to finding ways to celebrate his remarkable life in the future. 

Contribute to the John Q. Trojanowski, M.D., Ph.D. Memorial Fund at the Center for Neurodegenerative Disease Research

Latest Research

More News